[Cusabio] Available now! Target Proteins for Monkeypox, Smallpox, Cowpox, and Chickenpox Virus Resea
ÀÛ¼ºÀÚ
abbabio
ÀÛ¼ºÀÏÀÚ
2022-06-23
Á¶È¸¼ö
317
If you are unable to see the message below, click here to view.
Monkeypox, another challenge facing humanity
The COVID19 has not receded, and monkeypox has risen again. According to the latest news on the WHO official website, as of June 8, 2022, 1285 laboratory confirmed cases of monkeypox have been reported in 28 countries. Many of the confirmed and suspected cases of monkeypox have not been to the epidemic area, and the infection route of the patients is not yet clear.
In fact, monkeypox is a rare viral disease that is rarely found outside of Africa and does not spread easily from person to person. Given that, it has alarmed scientists and sent them racing for answers (Click to know more about Monkeypox):
CUSABIO responded urgently and organized a series of scientific research reagents related to Monkeypox virus and other pox virus including Smallpox, Chickenpox, Cowpox.